Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Divergence of Gold And Bitcoin – Which Represents A True Safe-Haven?

Recently, Mark Zuckerberg appeared before the US Congress to discuss his new Libra project and to attempt to calm concerns related to his new global alternate currency project. It appears this project is putting global political leaders in a particularly powerful position of e...
Chris Vermeulen | October 24, 2019 |

Biopharma to Accelerate Alzheimer Trial Completion

The upcoming catalysts for Axsome Therapeutics and the effects of COVID-19 on its clinical activities are discussed in an H.C. Wainwright & Co. report. In a March 20 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Axsome Therapeutics Inc. ...
Streetwise Reports | March 26, 2020 |

Biopharma's Phase 3 Trial Results in Migraine 'Robust,' 'Impressive'

These topline data and next steps for the therapeutic are reviewed in a Ladenburg Thalmann report. In a Dec. 30 research note, analyst Matthew Kaplan reported that Ladenburg Thalmann increased its price target on Buy-rated Axsome Therapeutics Inc. (AXSM:NASDAQ) to $...
Streetwise Reports | January 6, 2020 |

Buzz on the Bullboards: Old favourites make their return

September is often seen as a “fresh start” for the markets, like a new year on the stock exchange, but this party was met with a serious hangover in the shape of poor performances among sectors that only just recently began to turn around. One ma...
Jonathon Brown | September 14, 2023 |

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...
Dave Jackson | October 8, 2020 |

Surging Retail Sales, Cautious Powell, and Gold

Retail sales came in really strong in May, which could strengthen risk appetite, but the dovish Fed should support gold. However, the sales were still 6 percent lower than a year ago, which means that the coronavirus crisis has not ended yet. But such reports may, neve...
Arkadiusz Sieron | June 18, 2020 |

Will gold be Paulson's next "Greatest Trade Ever?"

When famed hedge-fund manager John Paulson speaks, people listen. And it's no wonder. Paulson made his way into the financial history books thanks to what many now call the "greatest trade ever." Paulson & Co. shorted the subprime mortgage market before the collapse ba...
Peter Krauth | October 28, 2012 |

Fed Stays Steady While BoJ Expands the Stimulus. What About Gold?

This week is hot for central banking: the Bank of Japan and the Federal Reserve have already held their monetary policy meetings. The former expanded its monetary policy easing, while the Fed remained steady. What do all these actions imply for the gold market? Bank of...
Arkadiusz Sieron | May 1, 2020 |

Will Central Banks Prevent Recession and Push Gold Down?

Will Central Banks Prevent Recession and Push Gold Down? Trade wars, geopolitical tensions and slowing economic indicators. Both the ECB and the Fed have recently cut interest rates to stimulate slowing growth, hoping to escape possible recession. Will they succeed? A...
Arkadiusz Sieron | October 28, 2019 |

How Well are Cannabis Stocks Performing in the Market?

At this time last year, cannabis stock was considered to be the hottest investment trend on Wall Street as Canada lifted the veil of recreational marijuana, and it was legally approved for sale for adult-use, on Oct 2018. Investors were hoping legal weed sales would grow t...
Ved Prakash | November 12, 2019 |
1 2 3 4 5 6 7 8 9 10 ...